Reshma Rangwala, EVP & Chief Medical Officer at Karyopharm Therapeutics Inc. (KPTI), sold 21,636 shares at $1.17 ($25K) on 2024-02-29, disclosed to the SEC on 2024-03-04.
Open-market sale of $25k KPTI by EVP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.17 | 15,667 | $18K | 71.9% |
| 2 | $1.20 | 5,969 | $7K | 28.1% |
| Total | $1.18 avg | 21,636 | $25K | 100% |
| Filing → |
| KPTI | SELL | 2026-03-03 | $48K | — | Filing → |
| KPTI | SELL | 2025-09-16 | $3K | — | Filing → |
| KPTI | SELL | 2025-04-24 | $3K | — | Filing → |